ConductScience.org, home

Gene · 407037

MIR320A: microRNA 320a

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MIR320A: microRNA 320a. Genes, record 407037. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/407037

On this page

Gene

Symbol
MIR320A
HGNC
Name
microRNA 320a
HGNC
NCBI Gene ID
407037
NCBI Gene
HGNC ID
HGNC:31632
HGNC
Ensembl
ENSG00000208037
NCBI Gene
Aliases
MIRN320, MIRN320A, hsa-mir-320, hsa-mir-320a, mir-320a
NCBI Gene
Type
ncRNA
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants826

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR320A papersNewest fiscal year
P30CA016058Cancer Center Support Grant92025
R35GM128753Molecular mechanisms for regulating microRNA levels in metazoans42025
P30DK058404Molecular and Cellular Basis for Digestive Diseases32025
R01ES004738Activated Macrophages and Ozone Toxicity32025
T32ES007148Training in Environmental Toxicology32025
U10CA180899Children's Oncology Group Statistics and Data Center32025
K12HD000849Reproductive Scientist Development Program22025
P01CA214091Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies22025
P01HL116263HDL Function in Human Disease22025
P30AG028740University of Florida Older Americans Independence Center (OAIC)22025

1 to 10 of 826Source NIH's project files

See all 826 nih grants

Papers2,743

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Radiotherapy Reconstitutes the Collapsed miRNome of Progressive Neuroblastoma and Promotes a Favorable Tumor Evolutionary Shift.Front Biosci (Landmark Ed)202642811996PubTator, text miningPubMed
Statement of Retraction: Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.Cancer Biol Ther202642811790PubTator, text miningPubMed
MicroRNA-206 as a Novel Potential Prognostic Biomarker for Distinguishing Philadelphia Chromosome-Positive and Negative ALL Patients.Int J Hematol Oncol Stem Cell Res202642756346PubTator, text miningPubMed
Noncoding RNAs as Prognostic Biomarkers After Myocardial Infarction: A Scoping Review.J Am Heart Assoc202642622088PubTator, text miningPubMed
Differential expression of salivary microRNA associated with keratoconus.Exp Eye Res202642567395PubTator, text miningPubMed
MicroRNA profiles as quality biomarkers in stored blood components: A narrative review.Vox Sang202642481401PubTator, text miningPubMed
Co-g-C3N4 Nanozyme-Based Colorimetric Biosensor for miR-320a Detection in Thyroid-Associated Ophthalmopathy.J Fluoresc202642455399PubTator, text miningPubMed
Circulating microRNAs as diagnostic biomarkers and pathogenic mediators in type 2 diabetic retinopathy: a systematic review.Acta Diabetol202642455341PubTator, text miningPubMed
Co-expressed microRNAs associated with elevated psychometabolic risk phenotype in women during midlife.Front Endocrinol (Lausanne)202642416907PubTator, text miningPubMed
Molecular Protein Interactions and Predictive Pathways as Biomarkers for Enhancing Volleyball Performance: A Narrative Review.Biomark Insights202642404021PubTator, text miningPubMed

1 to 10 of 2,743

See all 2,743 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/407037

GET https://conductscience.org/api/genes/v1/407037/grants?page=2